Lisa Sarzynski
Nationwide Children's Hospital
6 Papers
5 Citations
Lisa Sarzynski is an academic researcher from Nationwide Children's Hospital. The author has contributed to research in topics: Medicine & Attributable risk. The author has an hindex of 4, co-authored 6 publications. Previous affiliations of Lisa Sarzynski include Ohio State University.
Chat about Author
Papers
Being Overweight or Obese and the Development of Asthma
Jason E. Lang,Jason E. Lang,H. Timothy Bunnell,Jobayer Hossain,Tim Wysocki,John J. Lima,Terri H. Finkel,Leonard B. Bacharier,Amanda F. Dempsey,Lisa Sarzynski,Matthew Test,Christopher B. Forrest +11 more
TL;DR: Obesity is a major preventable risk factor for pediatric asthma and an estimated 23% to 27% of new asthma cases in children with obesity is directly attributable to obesity.
Metabolomic responses to lumacaftor/ivacaftor in cystic fibrosis.
Benjamin T. Kopp,Scott McCulloch,Chandra L. Shrestha,Shuzhong Zhang,Lisa Sarzynski,Lisa Sarzynski,Frederick W. Woodley,Frederick W. Woodley,Don Hayes,Don Hayes +9 more
TL;DR: Identifying biochemical biomarkers associated with drug response are clinically important for follow-up studies in patients with cystic fibrosis.
20
Home supply of emergency oral steroids and reduction in asthma healthcare utilization.
TL;DR: To determine if children with moderate‐to‐severe persistent asthma have decreased healthcare utilization after receiving a prescription and instructions to use an at home emergency supply of oral steroids during asthma exacerbations, a large number of children received a prescription.
6
Home Supply of Emergency Oral Steroids and Reduction in Asthma Healthcare Utilization
Abstract: To determine if children with moderate‐to‐severe persistent asthma have decreased healthcare utilization after receiving a prescription and instructions to use an at home emergency supply of oral steroids during asthma exacerbations.
3
Immunosuppression Drug Therapy in Lung Transplantation for Cystic Fibrosis
Pamela Burcham,Lisa Sarzynski,Lisa Sarzynski,Sabrina Khalfoun,Sabrina Khalfoun,Kimberly J. Novak,Julie C. Miller,Dmitry Tumin,Dmitry Tumin,Don Hayes +9 more
TL;DR: A review of immunosuppression regimens in the pediatric and adult CF post-LTx population is provided, investigating drug dosing and monitoring, and medication combinations.
2